Abiopharma

🔍 SHUGAR DANIEL S (Director)

Company: Nextpower Inc. (NXT)

Report Date: 2026-04-27

Detailed Transactions and Holdings:

• Sold 74,041 shares of Common Stock at $120.32 per share (Direct)
  Date: 2026-04-27 | Code: J | equity_swap_involved: 0 | shares_owned_after: 813,189.00 | transaction_form_type: 4 | Footnotes: F1, F1
• Sold 76,917 shares of Common Stock at $115.82 per share (Direct)
  Date: 2026-04-28 | Code: J | equity_swap_involved: 0 | shares_owned_after: 736,272.00 | transaction_form_type: 4 | Footnotes: F1, F1
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-04-27 | Code: H | nature_of_ownership: By Trust | shares_owned_after: 18,104.00 | Footnotes: F2, F2, F2

Footnotes:

• F1: Reflects the number of shares required to be sold pursuant to a "sell-to-cover" transaction in order to satisfy the tax withholding obligations in connection with the vesting and conversion of PSUs. These PSUs were earned upon the final certification by the Board of Directors of the Issuer on April 22, 2026 and the sell-to-cover transactions occurred over two trading days. These sales are mandated by the Issuer's "sell-to-cover" policy adopted by the Issuer on March 2, 2023 pursuant to the requirements of Rule 10b5-1 and its authority under its equity incentive plan, and do not represent discretionary trades by the Reporting Person.
• F2: Reflects shares indirectly beneficially owned by the Reporting Person through the Kathleen and Daniel Shugar Family Trust, dated May 10, 2007.